ARCHIMED's Fytexia has acquired B Natural, enhancing its product offerings in natural health supplements and expanding its research capabilities.
Information on the Target
Fytexia, a key subsidiary of ARCHIMED, specializes in the development and distribution of clinically proven natural ingredients for food supplements. Based in Béziers, France, the company sources nutrients derived from botanic polyphenols, which are potent antioxidants found in various plants, fruits, and vegetables. These antioxidants are known to mitigate risks related to numerous health concerns, including immune system functionality, metabolic processes, cardiovascular health, and obesity.
By acquiring B Natural, a leading player located in Milan, Italy, Fytexia aims to enhance its product offerings in the health nutrient sector. B Natural excels in the extraction, refinement, and commercialization of propolis, a bee-derived compound celebrated for its numerous health benefits, particularly in immune support. This strategic acquisition is anticipated to significantly boost Fytexia's sales and augment its research and development capabilities.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Italy
The health supplement industry in Italy is on a growth trajectory, fueled by a rising consumer interest in natural products and preventive healthcare. The market is characterized by a strong demand for dietary supplements that
Similar Deals
CARSO Group → Agro.biolab Laboratory
2023
Dr. Max → Farmacia Nuova della D.ssa Fantoni Beatrice e del Dott. Lodovichi Andrea & C. S.n.c., Farmacia del Vivo, Farmacia dell’Ospedale di Lavagnini D.ssa Marta e C. S.a.s.
2023
Fytexia
invested in
B Natural
in 2023
in a Buy & Build / Roll-Up deal